165 related articles for article (PubMed ID: 23081928)
81. Synthesis and antiproliferative evaluation of piperazine-1-carbothiohydrazide derivatives of indolin-2-one.
Lin HH; Wu WY; Cao SL; Liao J; Ma L; Gao M; Li ZF; Xu X
Bioorg Med Chem Lett; 2013 Jun; 23(11):3304-7. PubMed ID: 23602441
[TBL] [Abstract][Full Text] [Related]
82. Synthesis and antitumor activity evaluation of lamiridosin A derivatives.
Yang YX; Yan JW; Yan FL; Yin YY; Zhuang FF; Ji ZY
J Asian Nat Prod Res; 2016; 18(1):26-35. PubMed ID: 26757858
[TBL] [Abstract][Full Text] [Related]
83. 3-(3-Butylamino-2-hydroxy-propoxy)-1-hydroxy-xanthen-9-one acts as a topoisomerase IIα catalytic inhibitor with low DNA damage.
Park SE; Chang IH; Jun KY; Lee E; Lee ES; Na Y; Kwon Y
Eur J Med Chem; 2013 Nov; 69():139-45. PubMed ID: 24013413
[TBL] [Abstract][Full Text] [Related]
84. Design, synthesis and antiproliferative activity of a novel class of indole-2-carboxylate derivatives.
Ji XY; Xue ST; Zhan YC; Shen JJ; Wu LT; Jin J; Wang Z; Li ZR
Eur J Med Chem; 2014 Aug; 83():409-18. PubMed ID: 24996136
[TBL] [Abstract][Full Text] [Related]
85. Studies on gambogic acid (IV): Exploring structure-activity relationship with IκB kinase-beta (IKKβ).
Sun H; Chen F; Wang X; Liu Z; Yang Q; Zhang X; Zhu J; Qiang L; Guo Q; You Q
Eur J Med Chem; 2012 May; 51():110-23. PubMed ID: 22472167
[TBL] [Abstract][Full Text] [Related]
86. In vitro cytotoxic activity of novel protoflavone analogs - selectivity towards a multidrug resistant cancer cell line.
Danko B; Martins A; Chuang DW; Wang HC; Amaral L; Molnár J; Chang FR; Wu YC; Hunyadi A
Anticancer Res; 2012 Jul; 32(7):2863-9. PubMed ID: 22753749
[TBL] [Abstract][Full Text] [Related]
87. Design, synthesis, and biological evaluation of novel quinazolinyl-diaryl urea derivatives as potential anticancer agents.
Chen JN; Wang XF; Li T; Wu DW; Fu XB; Zhang GJ; Shen XC; Wang HS
Eur J Med Chem; 2016 Jan; 107():12-25. PubMed ID: 26560049
[TBL] [Abstract][Full Text] [Related]
88. Synthesis and biological evaluations of novel indenoisoquinolines as topoisomerase I inhibitors.
Zhang X; Wang R; Zhao L; Lu N; Wang J; You Q; Li Z; Guo Q
Bioorg Med Chem Lett; 2012 Jan; 22(2):1276-81. PubMed ID: 22079759
[TBL] [Abstract][Full Text] [Related]
89. Design, synthesis and cytotoxic activity of novel spin-labeled rotenone derivatives.
Liu YQ; Ohkoshi E; Li LH; Yang L; Lee KH
Bioorg Med Chem Lett; 2012 Jan; 22(2):920-3. PubMed ID: 22204911
[TBL] [Abstract][Full Text] [Related]
90. Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents.
Taher AT; Hegazy GH
Arch Pharm Res; 2013 May; 36(5):573-8. PubMed ID: 23471561
[TBL] [Abstract][Full Text] [Related]
91. Design, synthesis, and biological evaluation of 1,3,6,7-tetrahydroxyxanthone derivatives as phosphoglycerate mutase 1 inhibitors.
Jiang K; Gao B; Yu J; Jiang L; Niu A; Jia Y; Meng T; Zhou L; Wang J
Bioorg Med Chem Lett; 2021 Mar; 36():127820. PubMed ID: 33513389
[TBL] [Abstract][Full Text] [Related]
92. Novel R-(+)-limonene-based thiosemicarbazones and their antitumor activity against human tumor cell lines.
Vandresen F; Falzirolli H; Almeida Batista SA; da Silva-Giardini AP; de Oliveira DN; Catharino RR; Ruiz AL; de Carvalho JE; Foglio MA; da Silva CC
Eur J Med Chem; 2014 May; 79():110-6. PubMed ID: 24727464
[TBL] [Abstract][Full Text] [Related]
93. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.
Yoon YK; Ali MA; Wei AC; Choon TS; Osman H; Parang K; Shirazi AN
Bioorg Med Chem; 2014 Jan; 22(2):703-10. PubMed ID: 24387981
[TBL] [Abstract][Full Text] [Related]
94. Design, synthesis and antitumor activities of novel bis-aryl ureas derivatives as Raf kinase inhibitors.
Zhan W; Li Y; Huang W; Zhao Y; Yao Z; Yu S; Yuan S; Jiang F; Yao S; Li S
Bioorg Med Chem; 2012 Jul; 20(14):4323-9. PubMed ID: 22721924
[TBL] [Abstract][Full Text] [Related]
95. Design, synthesis and biological evaluations of chirally pure 1,2,3,4-tertrahydroisoquinoline analogs as anti-cancer agents.
Ramanivas T; Sushma B; Nayak VL; Chandra Shekar K; Srivastava AK
Eur J Med Chem; 2015 Mar; 92():608-18. PubMed ID: 25615796
[TBL] [Abstract][Full Text] [Related]
96. Research Progress in the Field of Gambogic Acid and Its Derivatives as Antineoplastic Drugs.
Li M; Su F; Zhu M; Zhang H; Wei Y; Zhao Y; Li J; Lv S
Molecules; 2022 May; 27(9):. PubMed ID: 35566290
[TBL] [Abstract][Full Text] [Related]
97. Design and synthesis of gambogic acid analogs as potent cytotoxic and anti-inflammatory agents.
Yen CT; Nakagawa-Goto K; Hwang TL; Morris-Natschke SL; Bastow KF; Wu YC; Lee KH
Bioorg Med Chem Lett; 2012 Jun; 22(12):4018-22. PubMed ID: 22595179
[TBL] [Abstract][Full Text] [Related]
98. Caged xanthone derivatives to promote mitochondria-mediated apoptosis in breast cancer cells.
Wang Y; Zheng H; Jiang X; Wu H; Ren Y; Xi Z; Zheng C; Xu H
Bioorg Med Chem; 2024 Apr; 103():117655. PubMed ID: 38493728
[TBL] [Abstract][Full Text] [Related]
99. Synthesis and biological evaluation of novel hydrogen sulfide releasing glycyrrhetic acid derivatives.
Song H; Sun Y; Xu G; Hou B; Ao G
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1457-63. PubMed ID: 26899462
[TBL] [Abstract][Full Text] [Related]
100. Synthesis and cytotoxic evaluation of eremophilane sesquiterpene 07H239-A derivatives.
Song YX; Cheng B; Zhu X; Qiao LT; Wang JJ; Gu YC; Li MF; Liu L; Lin YC
Chem Pharm Bull (Tokyo); 2011; 59(9):1186-9. PubMed ID: 21881269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
